WellPATH-PREVENT: A Mobile Intervention for Suicidal Ideation or Attempt
This study is testing a new mobile app called WellPATH-PREVENT for middle-aged and older adults (ages 50-90) who have recently been hospitalized for suicidal thoughts or a suicide attempt. The goal is to see if using the WellPATH-PREVENT app, which includes training and coaching, can help improve how you manage your emotions (called cognitive reappraisal) and reduce the risk of suicide. The study will enroll 115 participants. We are looking to see if WellPATH-PREVENT can help people feel better and reduce their risk of suicide after leaving the hospital. The study status is currently unclear.
- Study design
- This study is interventional and will involve about 115 participants. It has two phases: an initial 'proof-of-concept' phase and a second phase where participants will be randomly assigned to either an optimized WellPATH-PREVENT or a control group.
- What's involved
- You would use the WellPATH tablet app, attend training meetings during hospitalization, and have virtual coaching meetings after discharge for 6 or 12 weeks. You would also have assessments at study entry, discharge, and at various points up to 24 weeks, including an EEG (a test that measures brain activity).
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants in the R61 phase will be followed for 12 weeks, and participants in the R33 phase will be followed for 24 weeks after study entry.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
WellPATH-PREVENT: A Mobile Intervention for Middle-Aged and Older Adults Hospitalized for Suicidal Ideation or Attempt
At a glance
Conditions
NCT05183230
Where you'd take part
This study runs at 2 sites. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
New York Presbyterian Hospital/Weill Cornell Medicine
New York, New Yorkstudy coordinator listed
Not yet recruiting
Weill Cornell Institute of Geriatric Psychiatry, Weill Cornell Medicine
White Plains, New Yorkstudy coordinator listed
Recruiting
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Dimitris Kiosses, PhD · PRINCIPAL_INVESTIGATOR · Weill Medical College of Cornell University
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Want this trial checked against your situation?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Change in Event Related Potential - Late Positive Potential (ERP/LPP) - R61Study Entry, Week 6, Week 12
ERP is used to measure the amplitude (magnitude) of electrocortical activity (measured in μV) during an emotion regulation task.
- Change in Event Related Potential - Late Positive Potential (ERP/LPP) - R33Study Entry, Week 6, Week 12, Week 24
ERP is used to measure the amplitude (magnitude) of electrocortical activity (measured in μV) during an emotion regulation task.
- Change in Self-Reported Affect - R61Study Entry, Week 6, Week 12
Self-reported affect is used to study changes in negative emotions during an EEG emotion regulation task. It is based on a participant's rating of negative emotions (Likert scale: 1-5; 5 most negative) during the task.
- Change in Self-Reported Affect - R33Study Entry, Week 6, Week 12, Week 24
Self-reported affect is used to study changes in negative emotions during an EEG emotion regulation task. It is based on a participant's rating of negative emotions (Likert scale: 1-5; 5 most negative) during the task.
- Change in Emotion Regulation (Cognitive Reappraisal Subscale of ER Questionnaire) - R61Study Entry, Week 6, Week 12
ERQ is an interviewer-administered instrument to evaluate cognitive reappraisal ability. Scores can range from 1-7, where higher scores indicate greater use of emotion regulation strategies and lower scores indicate less frequent use of such strategies.
- Change in Emotion Regulation (Cognitive Reappraisal Subscale of ER Questionnaire) - R33Study Entry, Week 6, Week 12, Week 24
ERQ is an interviewer-administered instrument to evaluate cognitive reappraisal ability. Scores can range from 1-7, where higher scores indicate greater use of emotion regulation strategies and lower scores indicate less frequent use of such strategies.
- Change in Client Satisfaction with Treatment (CSQ) - R61Week 6, Week 12
Client Satisfaction Questionnaire is a self-report that measures patient satisfaction with intervention/treatment. Scores can range from 3-12, where higher values indicate higher satisfaction.
- Change in Client Satisfaction with Treatment (CSQ) - R33Week 6, Week 12, Week 24
Client Satisfaction Questionnaire is a self-report that measures patient satisfaction with intervention/treatment. Scores can range from 3-12, where higher values indicate higher satisfaction.
- Change in Suicide Risk - Columbia Suicide Severity Scale (C-SSRS) - R61Weekly from Study Entry to Week 12 (R61)
C-SSRS is used to measure intensity of suicidal ideation. Scores range from 0-5, where higher scores indicate more severe ideation.
- Change in Suicide Risk - Columbia Suicide Severity Scale (C-SSRS) - R33Weekly from Study Entry to Week 24
C-SSRS is used to measure intensity of suicidal ideation. Scores range from 0-5, where higher scores indicate more severe ideation.